Gene Ontology Comparison Results
Description of the problem:
Number of classes: 2
Number of genes: 6799
Number of genes that passed filtering criteria: 6799
Number of investigated GO categories: 1231
Random variance model was not used because distribution assumptions of this model were not satisfied
GO categories which discriminate among classes:
Table – Sorted by p-value of the LS permutation test.
The first 15 GO categories are significant at the nominal 0.01 level of the LS permutation test or KS permutation test
| GO category | GO description | Number of genes | LS Permutation p-value | KS Permutation p-value | |
|---|---|---|---|---|---|
| 1 | 0019992 | diacylglycerol binding | 11 | 0.00095 | 0.00018 |
| 2 | 0030532 | small nuclear ribonucleoprotein complex | 6 | 0.00111 | 0.0099 |
| 3 | 0016208 | AMP binding | 6 | 0.00496 | 0.12196 |
| 4 | 0015300 | solute\:solute antiporter activity | 6 | 0.00515 | 0.05095 |
| 5 | 0009072 | aromatic amino acid family metabolism | 7 | 0.00621 | 0.4628 |
| 6 | 0046148 | pigment biosynthesis | 7 | 0.00651 | 0.34548 |
| 7 | 0000160 | two-component signal transduction system (phosphorelay) | 5 | 0.00953 | 0.15316 |
| 8 | 0016779 | nucleotidyltransferase activity | 42 | 0.02063 | 0.00723 |
| 9 | 0051325 | interphase | 43 | 0.0393 | 0.00019 |
| 10 | 0051329 | interphase of mitotic cell cycle | 43 | 0.0393 | 0.00019 |
| 11 | 0000080 | G1 phase of mitotic cell cycle | 9 | 0.04143 | 0.00563 |
| 12 | 0051318 | G1 phase | 9 | 0.04143 | 0.00563 |
| 13 | 0019199 | transmembrane receptor protein kinase activity | 31 | 0.06295 | 0.00289 |
| 14 | 0000082 | G1/S transition of mitotic cell cycle | 29 | 0.08562 | 0.00556 |
| 15 | 0030934 | anchoring collagen | 5 | 0.14383 | 0.00528 |
Table Significant GO categories consist of the following genes:
| GO category | GO description | Description | Qiagen ID | GB acc | UG cluster | Gene symbol | Geometric mean of ratios ( Disease / Normal ) | p-value | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 0019992 | diacylglycerol binding | V-raf-1 murine leukemia viral oncogene homolog 1 | H002893_01 | X03484 | 85181 | RAF1 | 1.243 | 0.33932 |
| 2 | 0019992 | diacylglycerol binding | Rho/rac guanine nucleotide exchange factor (GEF) 2 | H003985_01 | AB014551 | 155120 | ARHGEF2 | 1.355 | 0.10846 |
| 3 | 0019992 | diacylglycerol binding | Protein kinase D2 | H005622_01 | AF151021 | 91146 | PKD2 | 0.803 | 0.46456 |
| 4 | 0019992 | diacylglycerol binding | Ras association (RalGDS/AF-6) domain family 1 | H008796_01 | AF061836 | 26931 | RASSF1 | 1.706 | 0.07124 |
| 5 | 0019992 | diacylglycerol binding | Chimerin (chimaerin) 1 | H011078_01 | X51408 | 169965 | CHN1 | 2.371 | 0.00707 |
| 6 | 0019992 | diacylglycerol binding | Cholinephosphotransferase 1 | H014496_01 | NM_020244 | 171889 | LOC56994 | 0.734 | 0.14947 |
| 7 | 0019992 | diacylglycerol binding | Rho-associated, coiled-coil containing protein kinase 2 | H001360_01 | NM_004850 | 58617 | ROCK2 | 0.841 | 0.22988 |
| 8 | 0019992 | diacylglycerol binding | Protein kinase C, gamma | H001596_01 | Z15114 | 2890 | PRKCG | 1.216 | 0.31059 |
| 9 | 0019992 | diacylglycerol binding | Diacylglycerol kinase, alpha (80kD) | H001620_01 | X62535 | 172690 | DGKA | 0.721 | 0.27692 |
| 10 | 0019992 | diacylglycerol binding | Protein kinase C, iota | H001676_01 | L33881 | 1904 | PRKCI | 0.627 | 0.09671 |
| 11 | 0019992 | diacylglycerol binding | Diacylglycerol kinase, zeta (104kD) | H001680_01 | U94905 | 89981 | DGKZ | 0.633 | 0.12362 |
| 12 | 0030532 | small nuclear ribonucleoprotein complex | DKFZP434D174 protein | H006736_01 | AL080150 | 302421 | DKFZP434D174 | 0.646 | 0.01071 |
| 13 | 0030532 | small nuclear ribonucleoprotein complex | U6 snRNA-associated Sm-like protein | H006779_01 | NM_012321 | 76719 | LSM4 | 1.217 | 0.34087 |
| 14 | 0030532 | small nuclear ribonucleoprotein complex | Small nuclear ribonucleoprotein polypeptide A' | H007604_01 | X13482 | 80506 | SNRPA1 | 0.764 | 0.08756 |
| 15 | 0030532 | small nuclear ribonucleoprotein complex | Gemin4 | H008741_01 | AF173856 | 19614 | GEMIN4 | 0.505 | 0.02841 |
| 16 | 0030532 | small nuclear ribonucleoprotein complex | U5 snRNP-specific protein (220 kD), ortholog of S. cerevisiae Prp8p | H009322_01 | AB007510 | 181368 | PRP8 | 0.961 | 0.74755 |
| 17 | 0030532 | small nuclear ribonucleoprotein complex | Nucleolar protein family A, member 1 (H/ACA small nucleolar RNPs) | H009404_01 | AJ276003 | 69851 | NOLA1 | 0.551 | 0.02424 |
| 18 | 0016208 | AMP binding | Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | H000645_01 | M33336 | 183037 | PRKAR1A | 1.244 | 0.00681 |
| 19 | 0016208 | AMP binding | Rap1 guanine-nucleotide-exchange factor directly activated by cAMP | H008675_01 | U78168 | 8578 | EPAC | 1.035 | 0.81688 |
| 20 | 0016208 | AMP binding | Cyclic nucleotide gated channel beta 1 | H009827_01 | AF042498 | 93909 | CNGB1 | 0.885 | 0.16333 |
| 21 | 0016208 | AMP binding | Acetyl-CoA synthetase | H009930_01 | AK000188 | 14779 | LOC55902 | 0.554 | 0.01774 |
| 22 | 0016208 | AMP binding | Hyperpolarization activated cyclic nucleotide-gated potassium channel 2 | H010769_01 | AJ012582 | 124161 | HCN2 | 1.202 | 0.44732 |
| 23 | 0016208 | AMP binding | KIAA1535 protein | H015256_01 | AB040968 | 284171 | KIAA1535 | 1.282 | 0.29396 |
| 24 | 0015300 | solute\:solute antiporter activity | Solute carrier family 22 (organic cation transporter), member 1-like | H001870_01 | AF030302 | 50868 | SLC22A1L | 0.783 | 0.37607 |
| 25 | 0015300 | solute\:solute antiporter activity | Solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | H004295_01 | AB026891 | 6682 | SLC7A11 | 1.331 | 0.00413 |
| 26 | 0015300 | solute\:solute antiporter activity | Solute carrier family 9 (sodium/hydrogen exchanger), isoform 5 | H006240_01 | AF111173 | 198295 | SLC9A5 | 1.356 | 0.31776 |
| 27 | 0015300 | solute\:solute antiporter activity | Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 | H006923_01 | J03592 | 164280 | SLC25A6 | 0.969 | 0.84669 |
| 28 | 0015300 | solute\:solute antiporter activity | Solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11 | H008432_01 | AF070548 | 184877 | SLC25A11 | 1.17 | 0.36497 |
| 29 | 0015300 | solute\:solute antiporter activity | Solute carrier family 9 (sodium/hydrogen exchanger), isoform 1 (antiporter, Na+/H+, amiloride | H001053_01 | S68616 | 170222 | SLC9A1 | 1.615 | 0.01454 |
| 30 | 0009072 | aromatic amino acid family metabolism | Tyrosine hydroxylase | H002673_01 | M17589 | 178237 | TH | 1.055 | 0.8706 |
| 31 | 0009072 | aromatic amino acid family metabolism | Tyrosinase (oculocutaneous albinism IA) | H003362_01 | M27160 | 2053 | TYR | 3.308 | 1e-04 |
| 32 | 0009072 | aromatic amino acid family metabolism | Silver (mouse homolog) like | H003494_01 | M77348 | 95972 | SILV | 0.864 | 0.67214 |
| 33 | 0009072 | aromatic amino acid family metabolism | Kynureninase (L-kynurenine hydrolase) | H005832_01 | U57721 | 169139 | KYNU | 0.771 | 0.36427 |
| 34 | 0009072 | aromatic amino acid family metabolism | Fumarylacetoacetate | H000004_01 | M55150 | 73875 | FAH | 1.093 | 0.81499 |
| 35 | 0009072 | aromatic amino acid family metabolism | Quinoid dihydropteridine reductase | H001542_01 | M16447 | 75438 | QDPR | 1.296 | 0.28212 |
| 36 | 0009072 | aromatic amino acid family metabolism | Phenylalanine hydroxylase | H001632_01 | U49897 | 1870 | PAH | 0.51 | 0.12984 |
| 37 | 0046148 | pigment biosynthesis | Tyrosinase (oculocutaneous albinism IA) | H003362_01 | M27160 | 2053 | TYR | 3.308 | 1e-04 |
| 38 | 0046148 | pigment biosynthesis | Silver (mouse homolog) like | H003494_01 | M77348 | 95972 | SILV | 0.864 | 0.67214 |
| 39 | 0046148 | pigment biosynthesis | Ferrochelatase (protoporphyria) | H005094_01 | D00726 | 26 | FECH | 0.67 | 0.18109 |
| 40 | 0046148 | pigment biosynthesis | Uroporphyrinogen III synthase (congenital erythropoietic porphyria) | H000636_01 | J03824 | 75593 | UROS | 1.487 | 0.12987 |
| 41 | 0046148 | pigment biosynthesis | Aminolevulinate, delta-, synthase 2 (sideroblastic/hypochromic anemia) | H008422_01 | X60364 | 323383 | ALAS2 | 1.085 | 0.87138 |
| 42 | 0046148 | pigment biosynthesis | Uroporphyrinogen decarboxylase | H009835_01 | AF104421 | 78601 | UROD | 0.971 | 0.75631 |
| 43 | 0046148 | pigment biosynthesis | Aminolevulinate, delta-, synthase 1 | H001696_01 | Y00451 | 78712 | ALAS1 | 1.093 | 0.65249 |
| 44 | 0000160 | two-component signal transduction system (phosphorelay) | Murine leukemia viral (bmi-1) oncogene homolog | H002850_01 | L13689 | 431 | BMI1 | 0.857 | 0.38405 |
| 45 | 0000160 | two-component signal transduction system (phosphorelay) | BUP protein | H008754_01 | NM_012071 | 35660 | BUP | 1.524 | 0.00307 |
| 46 | 0000160 | two-component signal transduction system (phosphorelay) | MMS19 (MET18 S. cerevisiae)-like | H011462_01 | AF007151 | 288891 | MMS19L | 0.759 | 0.40935 |
| 47 | 0000160 | two-component signal transduction system (phosphorelay) | Hypothetical protein FLJ23132 | H015444_01 | NM_025054 | 287727 | FLJ23132 | 0.933 | 0.62566 |
| 48 | 0000160 | two-component signal transduction system (phosphorelay) | Homo sapiens mRNA; cDNA DKFZp564I172 (from clone DKFZp564I172); complete CDS | H015715_01 | AL136635 | 300816 | 0.726 | 0.08272 | |
| 49 | 0016779 | nucleotidyltransferase activity | Unactive progesterone receptor, 23 kD | H001846_01 | L24804 | 278270 | P23 | 1.03 | 0.89309 |
| 50 | 0016779 | nucleotidyltransferase activity | 3'-phosphoadenosine 5'-phosphosulfate synthase 1 | H001876_01 | AF105227 | 3833 | PAPSS1 | 1.307 | 0.26494 |
| 51 | 0016779 | nucleotidyltransferase activity | Polymerase (DNA directed), gamma | H001903_01 | X98093 | 80961 | POLG | 1.118 | 0.59162 |
| 52 | 0016779 | nucleotidyltransferase activity | 2'-5'oligoadenylate synthetase 2 | H001966_01 | M87284 | 264981 | OAS2 | 0.744 | 0.50026 |
| 53 | 0016779 | nucleotidyltransferase activity | UDP-glucose pyrophosphorylase 2 | H002258_01 | U27460 | 77837 | UGP2 | 1.189 | 0.63283 |
| 54 | 0016779 | nucleotidyltransferase activity | Proliferating cell nuclear antigen | H002599_01 | M15796 | 78996 | PCNA | 0.875 | 0.66117 |
| 55 | 0016779 | nucleotidyltransferase activity | Telomerase reverse transcriptase | H002699_01 | AF015950 | 115256 | TERT | 0.937 | 0.62951 |
| 56 | 0016779 | nucleotidyltransferase activity | Polymerase (DNA directed), beta | H002879_01 | D29013 | 180107 | POLB | 1.092 | 0.77827 |
| 57 | 0016779 | nucleotidyltransferase activity | Polymerase (DNA directed), alpha | H003792_01 | X06745 | 267289 | POLA | 0.935 | 0.80067 |
| 58 | 0016779 | nucleotidyltransferase activity | Galactose-1-phosphate uridylyltransferase | H003947_01 | M60091 | 75641 | GALT | 1.672 | 0.12632 |
| 59 | 0016779 | nucleotidyltransferase activity | Topoisomerase-related function protein 4-1 | H004233_01 | AB005754 | 225951 | TRF4 | 1.363 | 0.42912 |
| 60 | 0016779 | nucleotidyltransferase activity | UDP-N-acetylglucosamine pyrophosphorylase 1 | H004589_01 | AB011004 | 21293 | UAP1 | 1.379 | 0.22684 |
| 61 | 0016779 | nucleotidyltransferase activity | Pericentriolar material 1 | H004678_01 | L27841 | 75737 | PCM1 | 0.719 | 0.17315 |
| 62 | 0016779 | nucleotidyltransferase activity | Phosphate cytidylyltransferase 1, choline, beta isoform | H004782_01 | AF052510 | 132794 | PCYT1B | 1.064 | 0.27452 |
| 63 | 0016779 | nucleotidyltransferase activity | Polymerase (RNA) III (DNA directed) (62kD) | H004821_01 | U93867 | 250745 | RPC62 | 1.378 | 0.12697 |
| 64 | 0016779 | nucleotidyltransferase activity | Polymerase (RNA) II (DNA directed) polypeptide B (140kD) | H005570_01 | X63563 | 296014 | POLR2B | 0.429 | 0.00651 |
| 65 | 0016779 | nucleotidyltransferase activity | Ubiquitin specific protease 14 (tRNA-guanine transglycosylase) | H006332_01 | U30888 | 75981 | USP14 | 0.898 | 0.65472 |
| 66 | 0016779 | nucleotidyltransferase activity | Nucleotide binding protein | H006333_01 | U18919 | 296422 | NBP | 1.374 | 0.13261 |
| 67 | 0016779 | nucleotidyltransferase activity | Poly(A) polymerase alpha | H006445_01 | X76770 | 49007 | PAPOLA | 1.457 | 0.0877 |
| 68 | 0016779 | nucleotidyltransferase activity | Polymerase (RNA) II (DNA directed) polypeptide H | H006451_01 | U37689 | 3128 | POLR2H | 1.246 | 0.1232 |
| 69 | 0016779 | nucleotidyltransferase activity | Polymerase (RNA) II (DNA directed) polypeptide L (7.6kD) | H006464_01 | U37690 | 71618 | POLR2L | 0.652 | 0.18083 |
| 70 | 0016779 | nucleotidyltransferase activity | Telomerase-associated protein 1 | H006594_01 | U86136 | 232070 | TEP1 | 0.966 | 0.82723 |
| 71 | 0016779 | nucleotidyltransferase activity | Polymerase (DNA-directed), mu | H006716_01 | AJ131891 | 46964 | POLM | 0.575 | 0.32178 |
| 72 | 0016779 | nucleotidyltransferase activity | Polymerase (RNA) II (DNA directed) polypeptide J (13.3kD) | H007101_01 | L37127 | 80475 | POLR2J | 0.765 | 0.1425 |
| 73 | 0016779 | nucleotidyltransferase activity | Hypothetical protein FLJ10509 | H007616_01 | AK001371 | 274319 | FLJ10509 | 1.587 | 0.10474 |
| 74 | 0016779 | nucleotidyltransferase activity | Similar to DNA-directed RNA polymerase I (135 kDa) | H007868_01 | AK001678 | 86337 | FLJ10816 | 0.838 | 0.24108 |
| 75 | 0016779 | nucleotidyltransferase activity | Polymerase (RNA) II (DNA directed) polypeptide K (7.0kD) | H007908_01 | Z47727 | 150675 | POLR2K | 0.891 | 0.67863 |
| 76 | 0016779 | nucleotidyltransferase activity | N-acetylneuraminic acid phosphate synthase; sialic acid synthase | H008206_01 | AK001659 | 274424 | SAS | 0.779 | 0.36438 |
| 77 | 0016779 | nucleotidyltransferase activity | Polymerase (DNA directed), gamma 2, accessory subunit | H008428_01 | U94703 | 30541 | POLG2 | 1.327 | 0.0338 |
| 78 | 0016779 | nucleotidyltransferase activity | Polymerase (RNA) II (DNA directed) polypeptide A (220kD) | H008768_01 | X63564 | 171880 | POLR2A | 1.279 | 0.41871 |
| 79 | 0016779 | nucleotidyltransferase activity | Polymerase (DNA directed), delta 2, regulatory subunit (50kD) | H000074_01 | U21090 | 74598 | POLD2 | 1.102 | 0.70683 |
| 80 | 0016779 | nucleotidyltransferase activity | Histone fold protein CHRAC17; DNA polymerase epsilon p17 subunit | H010753_01 | AF070640 | 108112 | CHRAC17 | 0.616 | 0.1856 |
| 81 | 0016779 | nucleotidyltransferase activity | Polymerase (RNA) II (DNA directed) polypeptide E (25kD) | H010908_01 | D38251 | 24301 | POLR2E | 0.821 | 0.37832 |
| 82 | 0016779 | nucleotidyltransferase activity | Transcriptional coactivator | H011559_01 | AF047002 | 241520 | ALY | 0.756 | 0.17392 |
| 83 | 0016779 | nucleotidyltransferase activity | Dyskeratosis congenita 1, dyskerin | H012214_01 | AF067008 | 4747 | DKC1 | 1.49 | 0.14225 |
| 84 | 0016779 | nucleotidyltransferase activity | Phosphate cytidylyltransferase 2, ethanolamine | H012323_01 | D84307 | 226377 | PCYT2 | 0.542 | 0.17937 |
| 85 | 0016779 | nucleotidyltransferase activity | BN51 (BHK21) temperature sensitivity complementing | H013188_01 | M17754 | 1276 | BN51T | 0.987 | 0.96033 |
| 86 | 0016779 | nucleotidyltransferase activity | CMP-N-acetylneuraminic acid synthase | H014153_01 | NM_018686 | 12492 | LOC55907 | 0.962 | 0.89372 |
| 87 | 0016779 | nucleotidyltransferase activity | DNA polymerase epsilon p12 subunit | H014636_01 | NM_019896 | 19980 | P12 | 0.666 | 0.17962 |
| 88 | 0016779 | nucleotidyltransferase activity | Hypothetical protein FLJ13390 similar to PAF53 | H014829_01 | NM_022490 | 24884 | FLJ13390 | 0.988 | 0.97023 |
| 89 | 0016779 | nucleotidyltransferase activity | Polymerase (RNA) II (DNA directed) polypeptide I (14.5kD) | H016370_01 | NM_006233 | 47062 | POLR2I | 1.137 | 0.4602 |
| 90 | 0016779 | nucleotidyltransferase activity | X-ray repair complementing defective repair in Chinese hamster cells 3 | H000124_01 | AF035586 | 99742 | XRCC3 | 1.422 | 0.23269 |
| 91 | 0051325 | interphase | Cyclin D1 (PRAD1: parathyroid adenomatosis 1) | H001999_01 | X59798 | 82932 | CCND1 | 1.251 | 0.36936 |
| 92 | 0051325 | interphase | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | H002149_01 | U03106 | 179665 | CDKN1A | 0.838 | 0.33129 |
| 93 | 0051325 | interphase | Cell division cycle 34 | H002232_01 | L22005 | 76932 | CDC34 | 1.415 | 0.21701 |
| 94 | 0051325 | interphase | Cyclin E1 | H002323_01 | M74093 | 9700 | CCNE1 | 1.288 | 0.47974 |
| 95 | 0051325 | interphase | Cyclin B1 | H002371_01 | M25753 | 23960 | CCNB1 | 0.675 | 0.15891 |
| 96 | 0051325 | interphase | Cyclin-dependent kinase 2 | H002412_01 | M68520 | 19192 | CDK2 | 1.853 | 0.11588 |
| 97 | 0051325 | interphase | Cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase) | H002606_01 | L20320 | 184298 | CDK7 | 1.055 | 0.83498 |
| 98 | 0051325 | interphase | Menage a trois 1 (CAK assembly factor) | H000312_01 | X87843 | 82380 | MNAT1 | 0.689 | 0.32732 |
| 99 | 0051325 | interphase | Cyclin A2 | H002740_01 | X51688 | 85137 | CCNA2 | 1.344 | 0.24008 |
| 100 | 0051325 | interphase | Cyclin G1 | H002889_01 | X77794 | 79101 | CCNG1 | 0.613 | 0.00464 |
| 101 | 0051325 | interphase | Cell division cycle 25C | H003048_01 | M34065 | 656 | CDC25C | 0.762 | 0.17709 |
| 102 | 0051325 | interphase | CDC6 (cell division cycle 6, S. cerevisiae) homolog | H003192_01 | U77949 | 69563 | CDC6 | 1.021 | 0.86789 |
| 103 | 0051325 | interphase | V-abl Abelson murine leukemia viral oncogene homolog 1 | H003207_01 | NM_005157 | 146355 | ABL1 | 1.038 | 0.88522 |
| 104 | 0051325 | interphase | General transcription factor IIH, polypeptide 1 (62kD subunit) | H003500_01 | M95809 | 89578 | GTF2H1 | 1.304 | 0.40518 |
| 105 | 0051325 | interphase | Cullin 2 | H000387_01 | U83410 | 82919 | CUL2 | 1.456 | 0.24367 |
| 106 | 0051325 | interphase | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | H003594_01 | U22398 | 106070 | CDKN1C | 1.211 | 0.40117 |
| 107 | 0051325 | interphase | Cell division cycle 2, G1 to S and G2 to M | H003739_01 | X05360 | 184572 | CDC2 | 0.503 | 0.10961 |
| 108 | 0051325 | interphase | Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | H003750_01 | AF004819 | 72901 | CDKN2B | 1.264 | 0.44457 |
| 109 | 0051325 | interphase | Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) | H003759_01 | U40343 | 29656 | CDKN2D | 0.909 | 0.73706 |
| 110 | 0051325 | interphase | Chromosome condensation 1 | H000401_01 | X12654 | 84746 | CHC1 | 0.789 | 0.22395 |
| 111 | 0051325 | interphase | Karyopherin alpha 2 (RAG cohort 1, importin alpha 1) | H004513_01 | U28386 | 159557 | KPNA2 | 0.832 | 0.76185 |
| 112 | 0051325 | interphase | Cell cycle progression 2 protein | H000462_01 | AF011792 | 170980 | CPR2 | 0.794 | 0.28286 |
| 113 | 0051325 | interphase | CDC28 protein kinase 2 | H000463_01 | X54942 | 83758 | CKS2 | 0.849 | 0.4051 |
| 114 | 0051325 | interphase | Homo sapiens cDNA FLJ20653 fis, clone KAT01739 | H005436_01 | AK000660 | 180059 | 1.389 | 0.13754 | |
| 115 | 0051325 | interphase | RNA, U17D small nucleolar | H005580_01 | AJ006835 | 196769 | RNU17D | 1.352 | 0.3504 |
| 116 | 0051325 | interphase | DnaJ (Hsp40) homolog, subfamily A, member 2 | H006052_01 | AF011793 | 21189 | DNAJA2 | 1.364 | 0.12707 |
| 117 | 0051325 | interphase | Cullin 4A | H006657_01 | U58090 | 183874 | CUL4A | 0.602 | 0.37343 |
| 118 | 0051325 | interphase | Cyclin-E binding protein 1 | H007016_01 | AB027289 | 26663 | LOC51191 | 1.057 | 0.91297 |
| 119 | 0051325 | interphase | Deleted in oral cancer (mouse, homolog) 1 | H000606_01 | AF006484 | 3436 | DOC1 | 0.941 | 0.64521 |
| 120 | 0051325 | interphase | G1 to S phase transition 1 | H000607_01 | X17644 | 2707 | GSPT1 | 1.06 | 0.69634 |
| 121 | 0051325 | interphase | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (S. cerevisiae CHL1-like helicase) | H007565_01 | U75967 | 27424 | DDX11 | 0.658 | 0.23892 |
| 122 | 0051325 | interphase | Cullin 5 | H008068_01 | X81882 | 101299 | CUL5 | 0.892 | 0.48091 |
| 123 | 0051325 | interphase | Cullin 1 | H008496_01 | AF062536 | 14541 | CUL1 | 0.824 | 0.17857 |
| 124 | 0051325 | interphase | Protein phosphatase 6, catalytic subunit | H008575_01 | X92972 | 279563 | PPP6C | 0.688 | 0.19804 |
| 125 | 0051325 | interphase | Branched chain aminotransferase 1, cytosolic | H008589_01 | U21551 | 157205 | BCAT1 | 1.516 | 0.15679 |
| 126 | 0051325 | interphase | GAP-associated tyrosine phosphoprotein p62 (Sam68) | H009232_01 | M88108 | 119537 | SAM68 | 0.663 | 0.15228 |
| 127 | 0051325 | interphase | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (S. cerevisiae CHL1-like helicase) | H009291_01 | U75968 | 27424 | DDX11 | 0.811 | 0.38746 |
| 128 | 0051325 | interphase | Cdk inhibitor p21 binding protein | H010584_01 | AB040450 | 279862 | TOK-1 | 0.875 | 0.63115 |
| 129 | 0051325 | interphase | Anaphase-promoting complex subunit 5 | H010633_01 | NM_016237 | 7101 | APC5 | 1.211 | 0.40229 |
| 130 | 0051325 | interphase | Homo sapiens ING1-like tumor suppressor protein mRNA, complete CDS | H015232_01 | AF149724 | 283948 | 0.858 | 0.22618 | |
| 131 | 0051325 | interphase | Cyclin T2 | H001491_01 | AF048731 | 155478 | CCNT2 | 0.884 | 0.75297 |
| 132 | 0051325 | interphase | Cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase) | H001670_01 | L25876 | 84113 | CDKN3 | 0.581 | 0.10101 |
| 133 | 0051325 | interphase | Dynamin 2 | H001738_01 | L36983 | 167013 | DNM2 | 1.065 | 0.74997 |
| 134 | 0051329 | interphase of mitotic cell cycle | Cyclin D1 (PRAD1: parathyroid adenomatosis 1) | H001999_01 | X59798 | 82932 | CCND1 | 1.251 | 0.36936 |
| 135 | 0051329 | interphase of mitotic cell cycle | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | H002149_01 | U03106 | 179665 | CDKN1A | 0.838 | 0.33129 |
| 136 | 0051329 | interphase of mitotic cell cycle | Cell division cycle 34 | H002232_01 | L22005 | 76932 | CDC34 | 1.415 | 0.21701 |
| 137 | 0051329 | interphase of mitotic cell cycle | Cyclin E1 | H002323_01 | M74093 | 9700 | CCNE1 | 1.288 | 0.47974 |
| 138 | 0051329 | interphase of mitotic cell cycle | Cyclin B1 | H002371_01 | M25753 | 23960 | CCNB1 | 0.675 | 0.15891 |
| 139 | 0051329 | interphase of mitotic cell cycle | Cyclin-dependent kinase 2 | H002412_01 | M68520 | 19192 | CDK2 | 1.853 | 0.11588 |
| 140 | 0051329 | interphase of mitotic cell cycle | Cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase) | H002606_01 | L20320 | 184298 | CDK7 | 1.055 | 0.83498 |
| 141 | 0051329 | interphase of mitotic cell cycle | Menage a trois 1 (CAK assembly factor) | H000312_01 | X87843 | 82380 | MNAT1 | 0.689 | 0.32732 |
| 142 | 0051329 | interphase of mitotic cell cycle | Cyclin A2 | H002740_01 | X51688 | 85137 | CCNA2 | 1.344 | 0.24008 |
| 143 | 0051329 | interphase of mitotic cell cycle | Cyclin G1 | H002889_01 | X77794 | 79101 | CCNG1 | 0.613 | 0.00464 |
| 144 | 0051329 | interphase of mitotic cell cycle | Cell division cycle 25C | H003048_01 | M34065 | 656 | CDC25C | 0.762 | 0.17709 |
| 145 | 0051329 | interphase of mitotic cell cycle | CDC6 (cell division cycle 6, S. cerevisiae) homolog | H003192_01 | U77949 | 69563 | CDC6 | 1.021 | 0.86789 |
| 146 | 0051329 | interphase of mitotic cell cycle | V-abl Abelson murine leukemia viral oncogene homolog 1 | H003207_01 | NM_005157 | 146355 | ABL1 | 1.038 | 0.88522 |
| 147 | 0051329 | interphase of mitotic cell cycle | General transcription factor IIH, polypeptide 1 (62kD subunit) | H003500_01 | M95809 | 89578 | GTF2H1 | 1.304 | 0.40518 |
| 148 | 0051329 | interphase of mitotic cell cycle | Cullin 2 | H000387_01 | U83410 | 82919 | CUL2 | 1.456 | 0.24367 |
| 149 | 0051329 | interphase of mitotic cell cycle | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | H003594_01 | U22398 | 106070 | CDKN1C | 1.211 | 0.40117 |
| 150 | 0051329 | interphase of mitotic cell cycle | Cell division cycle 2, G1 to S and G2 to M | H003739_01 | X05360 | 184572 | CDC2 | 0.503 | 0.10961 |
| 151 | 0051329 | interphase of mitotic cell cycle | Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | H003750_01 | AF004819 | 72901 | CDKN2B | 1.264 | 0.44457 |
| 152 | 0051329 | interphase of mitotic cell cycle | Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) | H003759_01 | U40343 | 29656 | CDKN2D | 0.909 | 0.73706 |
| 153 | 0051329 | interphase of mitotic cell cycle | Chromosome condensation 1 | H000401_01 | X12654 | 84746 | CHC1 | 0.789 | 0.22395 |
| 154 | 0051329 | interphase of mitotic cell cycle | Karyopherin alpha 2 (RAG cohort 1, importin alpha 1) | H004513_01 | U28386 | 159557 | KPNA2 | 0.832 | 0.76185 |
| 155 | 0051329 | interphase of mitotic cell cycle | Cell cycle progression 2 protein | H000462_01 | AF011792 | 170980 | CPR2 | 0.794 | 0.28286 |
| 156 | 0051329 | interphase of mitotic cell cycle | CDC28 protein kinase 2 | H000463_01 | X54942 | 83758 | CKS2 | 0.849 | 0.4051 |
| 157 | 0051329 | interphase of mitotic cell cycle | Homo sapiens cDNA FLJ20653 fis, clone KAT01739 | H005436_01 | AK000660 | 180059 | 1.389 | 0.13754 | |
| 158 | 0051329 | interphase of mitotic cell cycle | RNA, U17D small nucleolar | H005580_01 | AJ006835 | 196769 | RNU17D | 1.352 | 0.3504 |
| 159 | 0051329 | interphase of mitotic cell cycle | DnaJ (Hsp40) homolog, subfamily A, member 2 | H006052_01 | AF011793 | 21189 | DNAJA2 | 1.364 | 0.12707 |
| 160 | 0051329 | interphase of mitotic cell cycle | Cullin 4A | H006657_01 | U58090 | 183874 | CUL4A | 0.602 | 0.37343 |
| 161 | 0051329 | interphase of mitotic cell cycle | Cyclin-E binding protein 1 | H007016_01 | AB027289 | 26663 | LOC51191 | 1.057 | 0.91297 |
| 162 | 0051329 | interphase of mitotic cell cycle | Deleted in oral cancer (mouse, homolog) 1 | H000606_01 | AF006484 | 3436 | DOC1 | 0.941 | 0.64521 |
| 163 | 0051329 | interphase of mitotic cell cycle | G1 to S phase transition 1 | H000607_01 | X17644 | 2707 | GSPT1 | 1.06 | 0.69634 |
| 164 | 0051329 | interphase of mitotic cell cycle | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (S. cerevisiae CHL1-like helicase) | H007565_01 | U75967 | 27424 | DDX11 | 0.658 | 0.23892 |
| 165 | 0051329 | interphase of mitotic cell cycle | Cullin 5 | H008068_01 | X81882 | 101299 | CUL5 | 0.892 | 0.48091 |
| 166 | 0051329 | interphase of mitotic cell cycle | Cullin 1 | H008496_01 | AF062536 | 14541 | CUL1 | 0.824 | 0.17857 |
| 167 | 0051329 | interphase of mitotic cell cycle | Protein phosphatase 6, catalytic subunit | H008575_01 | X92972 | 279563 | PPP6C | 0.688 | 0.19804 |
| 168 | 0051329 | interphase of mitotic cell cycle | Branched chain aminotransferase 1, cytosolic | H008589_01 | U21551 | 157205 | BCAT1 | 1.516 | 0.15679 |
| 169 | 0051329 | interphase of mitotic cell cycle | GAP-associated tyrosine phosphoprotein p62 (Sam68) | H009232_01 | M88108 | 119537 | SAM68 | 0.663 | 0.15228 |
| 170 | 0051329 | interphase of mitotic cell cycle | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (S. cerevisiae CHL1-like helicase) | H009291_01 | U75968 | 27424 | DDX11 | 0.811 | 0.38746 |
| 171 | 0051329 | interphase of mitotic cell cycle | Cdk inhibitor p21 binding protein | H010584_01 | AB040450 | 279862 | TOK-1 | 0.875 | 0.63115 |
| 172 | 0051329 | interphase of mitotic cell cycle | Anaphase-promoting complex subunit 5 | H010633_01 | NM_016237 | 7101 | APC5 | 1.211 | 0.40229 |
| 173 | 0051329 | interphase of mitotic cell cycle | Homo sapiens ING1-like tumor suppressor protein mRNA, complete CDS | H015232_01 | AF149724 | 283948 | 0.858 | 0.22618 | |
| 174 | 0051329 | interphase of mitotic cell cycle | Cyclin T2 | H001491_01 | AF048731 | 155478 | CCNT2 | 0.884 | 0.75297 |
| 175 | 0051329 | interphase of mitotic cell cycle | Cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase) | H001670_01 | L25876 | 84113 | CDKN3 | 0.581 | 0.10101 |
| 176 | 0051329 | interphase of mitotic cell cycle | Dynamin 2 | H001738_01 | L36983 | 167013 | DNM2 | 1.065 | 0.74997 |
| 177 | 0000080 | G1 phase of mitotic cell cycle | Cyclin-dependent kinase 2 | H002412_01 | M68520 | 19192 | CDK2 | 1.853 | 0.11588 |
| 178 | 0000080 | G1 phase of mitotic cell cycle | Cell division cycle 25C | H003048_01 | M34065 | 656 | CDC25C | 0.762 | 0.17709 |
| 179 | 0000080 | G1 phase of mitotic cell cycle | CDC6 (cell division cycle 6, S. cerevisiae) homolog | H003192_01 | U77949 | 69563 | CDC6 | 1.021 | 0.86789 |
| 180 | 0000080 | G1 phase of mitotic cell cycle | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | H003594_01 | U22398 | 106070 | CDKN1C | 1.211 | 0.40117 |
| 181 | 0000080 | G1 phase of mitotic cell cycle | Cell division cycle 2, G1 to S and G2 to M | H003739_01 | X05360 | 184572 | CDC2 | 0.503 | 0.10961 |
| 182 | 0000080 | G1 phase of mitotic cell cycle | Cell cycle progression 2 protein | H000462_01 | AF011792 | 170980 | CPR2 | 0.794 | 0.28286 |
| 183 | 0000080 | G1 phase of mitotic cell cycle | Homo sapiens cDNA FLJ20653 fis, clone KAT01739 | H005436_01 | AK000660 | 180059 | 1.389 | 0.13754 | |
| 184 | 0000080 | G1 phase of mitotic cell cycle | DnaJ (Hsp40) homolog, subfamily A, member 2 | H006052_01 | AF011793 | 21189 | DNAJA2 | 1.364 | 0.12707 |
| 185 | 0000080 | G1 phase of mitotic cell cycle | Homo sapiens ING1-like tumor suppressor protein mRNA, complete CDS | H015232_01 | AF149724 | 283948 | 0.858 | 0.22618 | |
| 186 | 0051318 | G1 phase | Cyclin-dependent kinase 2 | H002412_01 | M68520 | 19192 | CDK2 | 1.853 | 0.11588 |
| 187 | 0051318 | G1 phase | Cell division cycle 25C | H003048_01 | M34065 | 656 | CDC25C | 0.762 | 0.17709 |
| 188 | 0051318 | G1 phase | CDC6 (cell division cycle 6, S. cerevisiae) homolog | H003192_01 | U77949 | 69563 | CDC6 | 1.021 | 0.86789 |
| 189 | 0051318 | G1 phase | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | H003594_01 | U22398 | 106070 | CDKN1C | 1.211 | 0.40117 |
| 190 | 0051318 | G1 phase | Cell division cycle 2, G1 to S and G2 to M | H003739_01 | X05360 | 184572 | CDC2 | 0.503 | 0.10961 |
| 191 | 0051318 | G1 phase | Cell cycle progression 2 protein | H000462_01 | AF011792 | 170980 | CPR2 | 0.794 | 0.28286 |
| 192 | 0051318 | G1 phase | Homo sapiens cDNA FLJ20653 fis, clone KAT01739 | H005436_01 | AK000660 | 180059 | 1.389 | 0.13754 | |
| 193 | 0051318 | G1 phase | DnaJ (Hsp40) homolog, subfamily A, member 2 | H006052_01 | AF011793 | 21189 | DNAJA2 | 1.364 | 0.12707 |
| 194 | 0051318 | G1 phase | Homo sapiens ING1-like tumor suppressor protein mRNA, complete CDS | H015232_01 | AF149724 | 283948 | 0.858 | 0.22618 | |
| 195 | 0019199 | transmembrane receptor protein kinase activity | Discoidin domain receptor family, member 2 | H001908_01 | X74764 | 71891 | DDR2 | 0.831 | 0.53593 |
| 196 | 0019199 | transmembrane receptor protein kinase activity | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 | H002029_01 | M34309 | 199067 | ERBB3 | 1.307 | 0.48426 |
| 197 | 0019199 | transmembrane receptor protein kinase activity | Fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) | H002119_01 | X66945 | 748 | FGFR1 | 0.861 | 0.34712 |
| 198 | 0019199 | transmembrane receptor protein kinase activity | Ret proto-oncogene (multiple endocrine neoplasia MEN2A, MEN2B and medullary thyroid carcinoma 1, Hir | H002140_01 | X12949 | 287270 | RET | 0.828 | 0.65442 |
| 199 | 0019199 | transmembrane receptor protein kinase activity | Fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, | H002197_01 | M87770 | 278581 | FGFR2 | 1.129 | 0.68541 |
| 200 | 0019199 | transmembrane receptor protein kinase activity | Neurotrophic tyrosine kinase, receptor, type 1 | H002234_01 | M23102 | 85844 | NTRK1 | 0.765 | 0.17994 |
| 201 | 0019199 | transmembrane receptor protein kinase activity | Fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) | H002448_01 | M64347 | 1420 | FGFR3 | 1.597 | 0.05694 |
| 202 | 0019199 | transmembrane receptor protein kinase activity | Fms-related tyrosine kinase 4 | H002485_01 | X69878 | 74049 | FLT4 | 0.756 | 0.37366 |
| 203 | 0019199 | transmembrane receptor protein kinase activity | Activin A receptor, type IIB | H002488_01 | X77533 | 23994 | ACVR2B | 0.642 | 0.03331 |
| 204 | 0019199 | transmembrane receptor protein kinase activity | EphA1 | H002568_01 | M18391 | 89839 | EPHA1 | 0.961 | 0.83855 |
| 205 | 0019199 | transmembrane receptor protein kinase activity | Kinase insert domain receptor (a type III receptor tyrosine kinase) | H002712_01 | AF035121 | 12337 | KDR | 0.74 | 0.11432 |
| 206 | 0019199 | transmembrane receptor protein kinase activity | Fibroblast growth factor receptor 4 | H002756_01 | L03840 | 165950 | FGFR4 | 0.649 | 0.23236 |
| 207 | 0019199 | transmembrane receptor protein kinase activity | Platelet-derived growth factor receptor, alpha polypeptide | H002775_01 | M21574 | 74615 | PDGFRA | 1.096 | 0.25256 |
| 208 | 0019199 | transmembrane receptor protein kinase activity | Ret finger protein | H000323_01 | J03407 | 142653 | RFP | 0.784 | 0.31172 |
| 209 | 0019199 | transmembrane receptor protein kinase activity | Macrophage stimulating 1 receptor (c-met-related tyrosine kinase) | H002936_01 | X70040 | 2942 | MST1R | 1.543 | 0.12996 |
| 210 | 0019199 | transmembrane receptor protein kinase activity | Discoidin domain receptor family, member 1 | H002955_01 | NM_013994 | 75562 | DDR1 | 0.792 | 0.55617 |
| 211 | 0019199 | transmembrane receptor protein kinase activity | Insulin-like growth factor 2 receptor | H003016_01 | Y00285 | 76473 | IGF2R | 0.813 | 0.33053 |
| 212 | 0019199 | transmembrane receptor protein kinase activity | Ephrin-A4 | H003069_01 | AJ006352 | 42331 | EFNA4 | 1.67 | 0.1254 |
| 213 | 0019199 | transmembrane receptor protein kinase activity | EphB4 | H003096_01 | U07695 | 155227 | EPHB4 | 0.849 | 0.29767 |
| 214 | 0019199 | transmembrane receptor protein kinase activity | RYK receptor-like tyrosine kinase | H003160_01 | S59184 | 79350 | RYK | 0.838 | 0.49926 |
| 215 | 0019199 | transmembrane receptor protein kinase activity | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene | H003542_01 | M11730 | 323910 | ERBB2 | 1.004 | 0.98391 |
| 216 | 0019199 | transmembrane receptor protein kinase activity | Neurotrophic tyrosine kinase, receptor, type 3 | H003588_01 | U05012 | 26776 | NTRK3 | 1.151 | 0.20942 |
| 217 | 0019199 | transmembrane receptor protein kinase activity | Platelet-derived growth factor receptor, beta polypeptide | H003752_01 | J03278 | 76144 | PDGFRB | 1.509 | 0.21888 |
| 218 | 0019199 | transmembrane receptor protein kinase activity | PTK7 protein tyrosine kinase 7 | H003804_01 | U33635 | 90572 | PTK7 | 1.351 | 0.22758 |
| 219 | 0019199 | transmembrane receptor protein kinase activity | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | H003808_01 | X06182 | 81665 | KIT | 0.788 | 0.49109 |
| 220 | 0019199 | transmembrane receptor protein kinase activity | Activin A receptor, type IB | H003853_01 | Z22536 | 99954 | ACVR1B | 1.179 | 0.26984 |
| 221 | 0019199 | transmembrane receptor protein kinase activity | C-mer proto-oncogene tyrosine kinase | H000425_01 | U08023 | 306178 | MERTK | 0.944 | 0.86201 |
| 222 | 0019199 | transmembrane receptor protein kinase activity | Homo sapiens cDNA FLJ11309 fis, clone PLACE1010076 | H006813_01 | AK002171 | 28005 | 1.2 | 0.52528 | |
| 223 | 0019199 | transmembrane receptor protein kinase activity | Latent transforming growth factor beta binding protein 1 | H000940_01 | M34057 | 241257 | LTBP1 | 0.82 | 0.49965 |
| 224 | 0019199 | transmembrane receptor protein kinase activity | Homo sapiens clone R2 ErbB-3 R2 (c-erbB-3) mRNA, partial CDS | H013267_01 | U88358 | 306251 | 1.182 | 0.39888 | |
| 225 | 0019199 | transmembrane receptor protein kinase activity | Platelet-derived growth factor receptor-like | H001341_01 | D37965 | 170040 | PDGFRL | 0.652 | 0.09963 |
| 226 | 0000082 | G1/S transition of mitotic cell cycle | Cyclin D1 (PRAD1: parathyroid adenomatosis 1) | H001999_01 | X59798 | 82932 | CCND1 | 1.251 | 0.36936 |
| 227 | 0000082 | G1/S transition of mitotic cell cycle | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | H002149_01 | U03106 | 179665 | CDKN1A | 0.838 | 0.33129 |
| 228 | 0000082 | G1/S transition of mitotic cell cycle | Cell division cycle 34 | H002232_01 | L22005 | 76932 | CDC34 | 1.415 | 0.21701 |
| 229 | 0000082 | G1/S transition of mitotic cell cycle | Cyclin E1 | H002323_01 | M74093 | 9700 | CCNE1 | 1.288 | 0.47974 |
| 230 | 0000082 | G1/S transition of mitotic cell cycle | Cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase) | H002606_01 | L20320 | 184298 | CDK7 | 1.055 | 0.83498 |
| 231 | 0000082 | G1/S transition of mitotic cell cycle | Menage a trois 1 (CAK assembly factor) | H000312_01 | X87843 | 82380 | MNAT1 | 0.689 | 0.32732 |
| 232 | 0000082 | G1/S transition of mitotic cell cycle | Cyclin A2 | H002740_01 | X51688 | 85137 | CCNA2 | 1.344 | 0.24008 |
| 233 | 0000082 | G1/S transition of mitotic cell cycle | Cyclin G1 | H002889_01 | X77794 | 79101 | CCNG1 | 0.613 | 0.00464 |
| 234 | 0000082 | G1/S transition of mitotic cell cycle | Cell division cycle 25C | H003048_01 | M34065 | 656 | CDC25C | 0.762 | 0.17709 |
| 235 | 0000082 | G1/S transition of mitotic cell cycle | CDC6 (cell division cycle 6, S. cerevisiae) homolog | H003192_01 | U77949 | 69563 | CDC6 | 1.021 | 0.86789 |
| 236 | 0000082 | G1/S transition of mitotic cell cycle | General transcription factor IIH, polypeptide 1 (62kD subunit) | H003500_01 | M95809 | 89578 | GTF2H1 | 1.304 | 0.40518 |
| 237 | 0000082 | G1/S transition of mitotic cell cycle | Cullin 2 | H000387_01 | U83410 | 82919 | CUL2 | 1.456 | 0.24367 |
| 238 | 0000082 | G1/S transition of mitotic cell cycle | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | H003594_01 | U22398 | 106070 | CDKN1C | 1.211 | 0.40117 |
| 239 | 0000082 | G1/S transition of mitotic cell cycle | Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | H003750_01 | AF004819 | 72901 | CDKN2B | 1.264 | 0.44457 |
| 240 | 0000082 | G1/S transition of mitotic cell cycle | Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) | H003759_01 | U40343 | 29656 | CDKN2D | 0.909 | 0.73706 |
| 241 | 0000082 | G1/S transition of mitotic cell cycle | Chromosome condensation 1 | H000401_01 | X12654 | 84746 | CHC1 | 0.789 | 0.22395 |
| 242 | 0000082 | G1/S transition of mitotic cell cycle | CDC28 protein kinase 2 | H000463_01 | X54942 | 83758 | CKS2 | 0.849 | 0.4051 |
| 243 | 0000082 | G1/S transition of mitotic cell cycle | RNA, U17D small nucleolar | H005580_01 | AJ006835 | 196769 | RNU17D | 1.352 | 0.3504 |
| 244 | 0000082 | G1/S transition of mitotic cell cycle | Cullin 4A | H006657_01 | U58090 | 183874 | CUL4A | 0.602 | 0.37343 |
| 245 | 0000082 | G1/S transition of mitotic cell cycle | Cyclin-E binding protein 1 | H007016_01 | AB027289 | 26663 | LOC51191 | 1.057 | 0.91297 |
| 246 | 0000082 | G1/S transition of mitotic cell cycle | G1 to S phase transition 1 | H000607_01 | X17644 | 2707 | GSPT1 | 1.06 | 0.69634 |
| 247 | 0000082 | G1/S transition of mitotic cell cycle | Cullin 5 | H008068_01 | X81882 | 101299 | CUL5 | 0.892 | 0.48091 |
| 248 | 0000082 | G1/S transition of mitotic cell cycle | Cullin 1 | H008496_01 | AF062536 | 14541 | CUL1 | 0.824 | 0.17857 |
| 249 | 0000082 | G1/S transition of mitotic cell cycle | Protein phosphatase 6, catalytic subunit | H008575_01 | X92972 | 279563 | PPP6C | 0.688 | 0.19804 |
| 250 | 0000082 | G1/S transition of mitotic cell cycle | Branched chain aminotransferase 1, cytosolic | H008589_01 | U21551 | 157205 | BCAT1 | 1.516 | 0.15679 |
| 251 | 0000082 | G1/S transition of mitotic cell cycle | GAP-associated tyrosine phosphoprotein p62 (Sam68) | H009232_01 | M88108 | 119537 | SAM68 | 0.663 | 0.15228 |
| 252 | 0000082 | G1/S transition of mitotic cell cycle | Cdk inhibitor p21 binding protein | H010584_01 | AB040450 | 279862 | TOK-1 | 0.875 | 0.63115 |
| 253 | 0000082 | G1/S transition of mitotic cell cycle | Cyclin T2 | H001491_01 | AF048731 | 155478 | CCNT2 | 0.884 | 0.75297 |
| 254 | 0000082 | G1/S transition of mitotic cell cycle | Cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase) | H001670_01 | L25876 | 84113 | CDKN3 | 0.581 | 0.10101 |
| 255 | 0030934 | anchoring collagen | Collagen, type VI, alpha 3 | H001981_01 | X52022 | 80988 | COL6A3 | 1.236 | 0.26989 |
| 256 | 0030934 | anchoring collagen | Collagen, type XVI, alpha 1 | H002090_01 | M92642 | 26208 | COL16A1 | 1.157 | 0.19594 |
| 257 | 0030934 | anchoring collagen | Collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive) | H002655_01 | L02870 | 1640 | COL7A1 | 1.292 | 0.26637 |
| 258 | 0030934 | anchoring collagen | Collagen, type VI, alpha 1 | H000774_01 | X15880 | 108885 | COL6A1 | 1.311 | 0.20447 |
| 259 | 0030934 | anchoring collagen | Homo sapiens, alpha-1 (VI) collagen | H001198_01 | M20776 | 25459 | 1.299 | 0.34272 |